Literature DB >> 2531500

Therapeutic options in treating acute myocardial infarction.

J W Danforth.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Homer A. Boushey, MD, Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531500      PMCID: PMC1026831     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  38 in total

Review 1.  Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris.

Authors:  M Packer
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

2.  Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

Authors:  R M Califf; E J Topol; B S George; J M Boswick; K L Lee; D Stump; J Dillon; C Abbottsmith; R J Candela; D J Kereiakes
Journal:  Circulation       Date:  1988-05       Impact factor: 29.690

3.  Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique.

Authors:  D C Siggers; C Salter; D C Fluck
Journal:  Br Heart J       Date:  1971-11

4.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

Review 5.  Local and regional regulation of coronary vascular tone.

Authors:  R J Bache; D J Dymek
Journal:  Prog Cardiovasc Dis       Date:  1981 Nov-Dec       Impact factor: 8.194

6.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

Authors:  W C Little; M Constantinescu; R J Applegate; M A Kutcher; M T Burrows; F R Kahl; W P Santamore
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

7.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

8.  Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.

Authors:  F J Wackers; M L Terrin; D S Kayden; G Knatterud; S Forman; E Braunwald; B L Zaret
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.

Authors:  H D White; J T Rivers; A H Maslowski; J A Ormiston; M Takayama; H H Hart; D N Sharpe; R M Whitlock; R M Norris
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

10.  Transmural cellular damage and blood flow distribution in early ischemia in pig hearts.

Authors:  H Fujiwara; M Ashraf; S Sato; R W Millard
Journal:  Circ Res       Date:  1982-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.